QURE short interest
uniQure N.V. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 8,715,837 |
|---|---|
| Change vs prior report | -1,204,675 (-12.1%) |
| Change over six months | -20.6% |
| Days to cover | 1.94 (sector: 3.78) |
| Average daily volume | 4,488,701 |
| Rank in Healthcare | #711 of 922 by days to cover |
QURE short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 8,715,837 | -12.1% | 1.94 | 4,488,701 |
| 2026-09-15 | 9,920,512 | +0.5% | 8.14 | 1,218,918 |
| 2026-08-31 | 9,874,417 | -8.3% | 9.42 | 1,048,356 |
| 2026-08-14 | 10,770,406 | +0.8% | 9.84 | 1,094,064 |
| 2026-07-31 | 10,683,529 | +3.0% | 6.79 | 1,572,428 |
| 2026-07-15 | 10,367,823 | -9.8% | 7.12 | 1,456,856 |
| 2026-06-30 | 11,494,705 | -2.6% | 2.57 | 4,466,160 |
| 2026-06-15 | 11,805,442 | +6.3% | 8.19 | 1,440,727 |
| 2026-05-29 | 11,100,357 | +7.8% | 9.04 | 1,228,078 |
| 2026-05-15 | 10,298,060 | -4.5% | 4.01 | 2,565,817 |
| 2026-04-30 | 10,784,518 | -2.8% | 7.03 | 1,533,215 |
| 2026-04-15 | 11,097,615 | +1.1% | 7.40 | 1,500,297 |
| 2026-03-31 | 10,981,448 | -13.7% | 5.53 | 1,985,368 |
| 2026-03-13 | 12,718,685 | +0.8% | 1.56 | 8,127,981 |
| 2026-02-27 | 12,617,484 | +17.6% | 3.31 | 3,807,566 |
| 2026-02-13 | 10,727,684 | -5.9% | 5.18 | 2,069,859 |
| 2026-01-30 | 11,396,509 | -1.5% | 6.62 | 1,721,848 |
| 2026-01-15 | 11,569,838 | -3.6% | 5.87 | 1,969,383 |
| 2025-12-31 | 11,996,689 | +33.8% | 4.35 | 2,755,072 |
| 2025-12-15 | 8,966,485 | +7.6% | 3.05 | 2,943,760 |
| 2025-11-28 | 8,335,603 | -0.7% | 4.37 | 1,907,330 |
| 2025-11-14 | 8,390,666 | +21.6% | 1.14 | 7,377,153 |
| 2025-10-31 | 6,901,368 | -8.9% | 3.98 | 1,731,878 |
| 2025-10-15 | 7,573,225 | -31.4% | 2.37 | 3,195,780 |
| 2025-09-30 | 11,032,065 | +33.3% | 1.01 | 10,870,960 |
import finzdata as yf
yf.Ticker("QURE").short_interest # every report since 2017
yf.Client().short_interest(["QURE"], start="2018-01-01")Healthcare short interest · QURE price history · Who owns QURE · All short interest